PEPTIDERGIC MODULATION OF SYMPATHETIC COTRANSMISSION
Project Number5F05TW004978-02
Contact PI/Project LeaderMUTAFOVA-YAMBOLIEVA, VIOLETA N.
Awardee OrganizationUNIVERSITY OF NEVADA RENO
Description
Abstract Text
The proposed research during the fellowship will provide me with vital
experience of sympathetic nervous system activity studies. Thus, my main
goals for this period are: (i) To study the modulating effects of
cardiovascular peptides ET, ANP, and BNP on the pre- and postsynaptic
mechanisms of peripheral sympathetic cotransmission at the levels of
isolated tissues in vitro and of an organism devoided of central reflexes
in vivo as well as to study the participation of the endothelium, the
EDRF/NO, cGMP, IP3, and Ca++ in these effects; (ii) To learn the basic
techniques necessary for studies on peripheral sympathetic
cotransmission, particularly those related to a) transmitter (ATP and
NE) release measurement, b) contractile responses in isolated blood
vessels, c) intracellular Ca++ and cyclic nucleotide signaling and
d) hemodynamics of pitched animals (see Item 21, Research plan).
Professor Westfall's laboratory is an ideal place to study the role of
endogenous peptides on sympathetic neurotransmission. Professor David
Westfall and his group have played a fundamental role in developing the
concept that sympathetic neurotransmission involves the release of the
cotransmitters ATP and NE. In addition his group has recently developed
the concept that prejunctional purinoceptors, which modulate
neurotransmitter release, may exist as several subtype. The laboratory
is also well known for its ability to develop new methodologies to apply
to issues of neurotransmission. For example, his laboratory is one of
the few in the world where the release of ATP and NE can be
simultaneously evaluated. The opportunity to learn and work in such an
environment particularly in a place where the research interests are so
congruent with my own, will no doubt enhance the development of my
scientific career.
John E. Fogarty International Center for Advanced Study in the Health Sciences
CFDA Code
DUNS Number
146515460
UEI
WLDGTNCFFJZ3
Project Start Date
20-September-1994
Project End Date
Budget Start Date
20-September-1994
Budget End Date
19-September-1995
Project Funding Information for 1994
Total Funding
$36,513
Direct Costs
$36,513
Indirect Costs
Year
Funding IC
FY Total Cost by IC
1994
John E. Fogarty International Center for Advanced Study in the Health Sciences
$36,513
Year
Funding IC
FY Total Cost by IC
Sub Projects
No Sub Projects information available for 5F05TW004978-02
Publications
Publications are associated with projects, but cannot be identified with any particular year of the project or fiscal year of funding. This is due to the continuous and cumulative nature of knowledge generation across the life of a project and the sometimes long and variable publishing timeline. Similarly, for multi-component projects, publications are associated with the parent core project and not with individual sub-projects.
No Publications available for 5F05TW004978-02
Patents
No Patents information available for 5F05TW004978-02
Outcomes
The Project Outcomes shown here are displayed verbatim as submitted by the Principal Investigator (PI) for this award. Any opinions, findings, and conclusions or recommendations expressed are those of the PI and do not necessarily reflect the views of the National Institutes of Health. NIH has not endorsed the content below.
No Outcomes available for 5F05TW004978-02
Clinical Studies
No Clinical Studies information available for 5F05TW004978-02
News and More
Related News Releases
No news release information available for 5F05TW004978-02
History
No Historical information available for 5F05TW004978-02
Similar Projects
No Similar Projects information available for 5F05TW004978-02